149
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Time-Related Vascular Inflammatory Response to COVID-19 Assessed by 18F-FDG PET/CT in Follow-Up Tumor Patients

ORCID Icon, , , , , & show all
Pages 3109-3117 | Received 25 Apr 2023, Accepted 12 Jul 2023, Published online: 24 Jul 2023

References

  • Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206. doi:10.1111/joim.13091
  • Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831–840. doi:10.1001/jamacardio.2020.1286
  • Manson JJ, Crooks C, Naja M, et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheumatol. 2020;2(10):e594–e602. doi:10.1016/S2665-9913(20)30275-7
  • Szekely Y, Gilead R, Réa A, Lawler PR. An evolving understanding of the basis and management of vascular complications of COVID-19: where do we go from here. Can J Cardiol. 2023. doi:10.1016/j.cjca.2023.03.019
  • Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128. doi:10.1056/NEJMoa2015432
  • Yao S, Luo N, Liu J, et al. Elevated serum levels of progranulin and soluble vascular cell adhesion molecule-1 in patients with COVID-19. J Inflamm Res. 2021;14:4785–4794. doi:10.2147/JIR.S330356
  • Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32(6):674–681. doi:10.1007/s00259-004-1757-9
  • Jamar F, Gormsen LC, Yildiz H, Slart RH, van der Geest KS, Gheysens O. The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response. Q J Nucl Med Mol Imaging. 2022;66(3):182–193. doi:10.23736/S1824-4785.22.03465-3
  • Treglia G, Albano D, Dondi F, Bertagna F, Gheysens O. A role of FDG PET/CT for response assessment in large vessel disease. Semin Nucl Med. 2023;53(1):78–85. doi:10.1053/j.semnuclmed.2022.08.002
  • Kurch L, Hüttmann A, Georgi TW, et al. Interim PET in Diffuse Large B-Cell Lymphoma. J Nucl Med. 2021;62(8):1068–1074. doi:10.2967/jnumed.120.255034
  • Slart R. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45(7):1250–1269. doi:10.1007/s00259-018-3973-8
  • Dudouet P, Cammilleri S, Guedj E, Jacquier A, Raoult D, Eldin C. Aortic (18)F-FDG PET/CT hypermetabolism in patients with long COVID: a retrospective study. Clin Microbiol Infect. 2021;27(12):1873–1875. doi:10.1016/j.cmi.2021.09.020
  • Melillo F, Napolano A, Loffi M, et al. Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19. Eur J Clin Invest. 2022;52(1):e13703. doi:10.1111/eci.13703
  • Evans PC, Rainger GE, Mason JC, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res. 2020;116(14):2177–2184. doi:10.1093/cvr/cvaa230
  • Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5
  • Terentes-Printzios D, Gardikioti V, Solomou E, et al. The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness. Hypertens Res. 2022;45(5):846–855. doi:10.1038/s41440-022-00876-6
  • Kusmirek JE, Magnusson JD, Perlman SB. Current applications for nuclear medicine imaging in pulmonary disease. Curr Pulmonol Rep. 2020;9(3):82–95. doi:10.1007/s13665-020-00251-1
  • Jamar F, Buscombe J, Chiti A, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–658. doi:10.2967/jnumed.112.112524
  • Sollini M, Morbelli S, Ciccarelli M, et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48(10):3187–3197. doi:10.1007/s00259-021-05294-3
  • Sollini M, Ciccarelli M, Cecconi M, et al. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2021;48(5):1460–1466. doi:10.1007/s00259-020-05084-3
  • Alavi A, Werner TJ, Gholamrezanezhad A. The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection. Eur J Nucl Med Mol Imaging. 2021;48(4):956–962. doi:10.1007/s00259-020-05148-4